As a pharmaceutical/healthcare professional, you know how valuable KOLs are to your organisation and how they contribute to the success of your clinical research. In today's competitive and challenging market, it is vital that relationship between the pharmaceutical/healthcare industry and KOLs are not only built but nurtured and maintained.

Identifying and engaging KOLs for your organisation is crucial to the success of your product. Entering European markets is a challenge faced by the pharmaceutical industry with ever-changing pricing structures and regulations. Working closely and adopting a culture of transparent collaboration and engagement with KOLs helps overcome some of these challenges.
SMi is proud to present KOL Knowledge Leaders focussed to keepour audience up-to-date with developments in the ever-changing KOL sphere.

Reasons why you should attend:

• Hear directly from Key Opinion Leaders
• Find out about all the latest regulatory guidance in the European markets
• Identify and engage with KOL through effective social media and traditional channels
• Gain an insight into current transparent and flexible relationships
• Improve your relationship with key leaders
• Overcoming cultural barriers and dealing with change management
• Establishing the return on investment for your KOL and MSL management
• Develop a successful KOL management program

PLUS TWO INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS
Tuesday 25th September 2012, Copthorne Tara Hotel, London

Workshop A: The implications of the Bribery Act 2010 for pharmaceutical/ healthcare companies’ relationships with KOLs

Workshop leader: Shaul Brazil, Barrister, BCL Burton Copeland 8.30am - 12.45pm

Workshop B: Engaging KOLS in Market Access

Workshop leader: Miriam George, CEO, PDC Healthcare 1.30pm - 5.30pm

For further information click here